McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
| trading_symbol | registrant_name | time | price | change | percentage_change | 
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 2025-10-30 18:35:05 | 813.23 | -12.3 | -1.49 | 
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCK | 0000927653 | MCKESSON CORP | US58155Q1031 | 549300WZWOM80UCFSF54 | 943207296 | NYSE | 5122 | Wholesale-Drugs, Proprietaries & Druggists' Sundries | 0331 | DE | 6555 STATE HIGHWAY 161 | IRVING | TX | 75039 | UNITED STATES | US | 972-446-4800 | 6555 STATE HIGHWAY 161, IRVING, TX, 75039 | 6555 STATE HIGHWAY 161, IRVING, TX, 75039 | MCKESSON HBOC INC | Healthcare | 1833 | Brian S. Tyler | 45,000 | http://mckesson.com | 62,700,000,000 | 280,000,000 | 124,384,393 | McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". | 2025-10-30 12:11:54 | 
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding | 
|---|---|---|---|---|---|---|
| 2025 | 62,700,000,000 | 4,900,000,000 | 8.4775 | 125,112,236 | -4,873,278 | -3.7491 | 
| 2024 | 57,800,000,000 | 9,600,000,000 | 19.917 | 129,985,514 | -5,616,748 | -4.1421 | 
| 2023 | 48,200,000,000 | 17,800,000,000 | 58.5526 | 135,602,262 | -9,763,062 | -6.7162 | 
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation | 
|---|---|---|---|---|---|---|---|---|
| Michele Lau | Chief Legal Officer, Executive Vice President | 2025 | 720,417 | 0 | 3,001,093 | 857,296 | 647,899 | 5,226,705 | 
| Leann B. Smith | Executive Vice President | 2025 | 658,750 | 0 | 2,200,981 | 783,913 | 74,255 | 3,717,899 | 
| Brian S. Tyler | Chief Executive Officer | 2025 | 1,541,667 | 0 | 14,500,512 | 3,669,167 | 450,368 | 20,161,714 | 
| Britt J. Vitaloneexecutive Vice | President | 2025 | 1,025,000 | 0 | 5,000,853 | 1,524,688 | 131,640 | 7,682,181 | 
| Thomas L. Rodgers | Executive Vice President | 2025 | 631,117 | 0 | 1,751,295 | 751,029 | 79,866 | 3,213,307 | 
| Fiscal Year | Employee Count | 
|---|---|
| 2025 | 45,000 | 
| 2024 | 51,000 | 
| 2023 | 51,000 | 
| Fiscal Year | 2025 | 2024 | 2023 | 
|---|---|---|---|
| Revenue | 359,051,000,000 | 308,951,000,000 | 276,711,000,000 | 
| Cost Of Revenue | 345,728,000,000 | 296,123,000,000 | 264,353,000,000 | 
| Gross Profit | 13,323,000,000 | 12,828,000,000 | 12,358,000,000 | 
| Research And Development Expenses | — | — | — | 
| General And Administrative Expenses | 8,507,000,000 | 8,657,000,000 | 7,776,000,000 | 
| Operating Expenses | 8,901,000,000 | 8,919,000,000 | 7,977,000,000 | 
| Operating Income | 4,422,000,000 | 3,909,000,000 | 4,381,000,000 | 
| Net Income | 3,295,000,000 | 3,002,000,000 | 3,560,000,000 | 
| Earnings Per Share Basic | 25.86 | 22.54 | 25.23 | 
| Earnings Per Share Diluted | 25.72 | 22.39 | 25.03 | 
| Weighted Average Shares Outstanding Basic | 127,400,000 | 133,200,000 | 141,100,000 | 
| Weighted Average Shares Outstanding Diluted | 128,100,000 | 134,100,000 | 142,200,000 | 
| Fiscal Year | 2025 | 2024 | 2023 | 
|---|---|---|---|
| Cash And Cash Equivalents | 5,691,000,000 | 4,583,000,000 | 4,678,000,000 | 
| Marketable Securities Current | — | — | — | 
| Accounts Receivable | 25,643,000,000 | 21,622,000,000 | 19,410,000,000 | 
| Inventories | 23,001,000,000 | 21,139,000,000 | 19,691,000,000 | 
| Non Trade Receivables | — | — | — | 
| Other Assets Current | — | — | — | 
| Total Assets Current | 55,398,000,000 | 47,970,000,000 | 44,292,000,000 | 
| Marketable Securities Non Current | — | — | — | 
| Property Plant And Equipment | 2,502,000,000 | 2,316,000,000 | 2,177,000,000 | 
| Other Assets Non Current | 3,972,000,000 | 3,186,000,000 | 1,992,000,000 | 
| Total Assets Non Current | 19,742,000,000 | 19,473,000,000 | 18,028,000,000 | 
| Total Assets | 75,140,000,000 | 67,443,000,000 | 62,320,000,000 | 
| Accounts Payable | 55,330,000,000 | 47,097,000,000 | 42,490,000,000 | 
| Deferred Revenue | — | — | — | 
| Short Term Debt | 1,191,000,000 | 50,000,000 | 968,000,000 | 
| Other Liabilities Current | 4,825,000,000 | 4,915,000,000 | 4,195,000,000 | 
| Total Liabilities Current | 61,604,000,000 | 52,357,000,000 | 47,957,000,000 | 
| Long Term Debt | 5,654,000,000 | 5,629,000,000 | 5,594,000,000 | 
| Other Liabilities Non Current | 2,659,000,000 | 2,610,000,000 | 1,813,000,000 | 
| Total Liabilities Non Current | -61,557,000,000 | -52,316,000,000 | -47,904,000,000 | 
| Total Liabilities | 47,000,000 | 41,000,000 | 53,000,000 | 
| Common Stock | 3,000,000 | 3,000,000 | 3,000,000 | 
| Retained Earnings | 17,921,000,000 | 14,978,000,000 | 12,295,000,000 | 
| Accumulated Other Comprehensive Income | -932,000,000 | -881,000,000 | -905,000,000 | 
| Total Shareholders Equity | -2,074,000,000 | -1,971,000,000 | -1,857,000,000 | 
| Fiscal Year | 2025 | 2024 | 2023 | 
|---|---|---|---|
| Depreciation And Amortization | 394,000,000 | 382,000,000 | 360,000,000 | 
| Share Based Compensation Expense | 141,000,000 | 110,000,000 | 75,000,000 | 
| Other Non Cash Income Expense | -424,000,000 | -233,000,000 | -298,000,000 | 
| Change In Accounts Receivable | 3,935,000,000 | 2,954,000,000 | 1,082,000,000 | 
| Change In Inventories | 2,270,000,000 | 1,294,000,000 | 1,259,000,000 | 
| Change In Non Trade Receivables | — | — | — | 
| Change In Other Assets | — | — | — | 
| Change In Accounts Payable | 8,301,000,000 | 4,587,000,000 | 3,788,000,000 | 
| Change In Other Liabilities | 281,000,000 | -37,000,000 | -56,000,000 | 
| Cash From Operating Activities | 6,085,000,000 | 4,314,000,000 | 5,159,000,000 | 
| Purchases Of Marketable Securities | — | — | — | 
| Sales Of Marketable Securities | — | — | — | 
| Acquisition Of Property Plant And Equipment | 859,000,000 | 687,000,000 | 558,000,000 | 
| Acquisition Of Business | 24,000,000 | 272,000,000 | 867,000,000 | 
| Other Investing Activities | 29,000,000 | 160,000,000 | 194,000,000 | 
| Cash From Investing Activities | -733,000,000 | -1,072,000,000 | -542,000,000 | 
| Tax Withholding For Share Based Compensation | — | — | — | 
| Payments Of Dividends | 352,000,000 | 320,000,000 | 296,000,000 | 
| Issuance Of Common Stock | — | — | — | 
| Repurchase Of Common Stock | 3,172,000,000 | 3,023,000,000 | 3,665,000,000 | 
| Issuance Of Long Term Debt | 498,000,000 | 991,000,000 | 997,000,000 | 
| Repayment Of Long Term Debt | 519,000,000 | 288,000,000 | 1,274,000,000 | 
| Other Financing Activities | -554,000,000 | -175,000,000 | -324,000,000 | 
| Cash From Financing Activities | -3,965,000,000 | -3,342,000,000 | -4,368,000,000 | 
| Change In Cash | 1,371,000,000 | -94,000,000 | 744,000,000 | 
| Cash At End Of Period | 5,691,000,000 | 4,583,000,000 | 4,678,000,000 | 
| Income Taxes Paid | 1,124,000,000 | 901,000,000 | 562,000,000 | 
| Interest Paid | 273,000,000 | 234,000,000 | 224,000,000 | 
| Fiscal Year | 2025 | 2024 | 2023 | 
|---|---|---|---|
| Earnings Per Share | 25.86 | 22.54 | 25.23 | 
| Price To Earnings Ratio | 26.0244 | 23.8017 | 14.1122 | 
| Earnings Growth Rate | 14.7294 | -10.6619 | 244.6721 | 
| Price Earnings To Growth Ratio | 1.7668 | -2.2324 | 0.0577 | 
| Book Value Per Share | 589.427 | 506.021 | 441.297 | 
| Price To Book Ratio | 1.1418 | 1.0602 | 0.8068 | 
| Ebitda | 5,078,000,000 | 4,537,000,000 | 4,730,000,000 | 
| Enterprise Value | 86,892,926,000 | 72,556,468,000 | 52,122,655,000 | 
| Dividend Yield | 0.0041 | 0.0045 | 0.0059 | 
| Dividend Payout Ratio | 0.1068 | 0.1066 | 0.0831 | 
| Debt To Equity Ratio | -3.3004 | -2.8813 | -3.5337 | 
| Capital Expenditures | 580,000,000 | 521,000,000 | 445,000,000 | 
| Free Cash Flow | 5,505,000,000 | 3,793,000,000 | 4,714,000,000 | 
| Return On Equity | -1.5887 | -1.5231 | -1.9171 | 
| One Year Beta | 0.0586 | -0.0181 | 0.3911 | 
| Three Year Beta | 0.2577 | 0.3683 | 0.6097 | 
| Five Year Beta | 0.4919 | 0.7207 | 0.7721 | 
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction | 
|---|---|---|---|---|---|
| TYLER BRIAN S. | Director, Chief Executive Officer | 2025-08-22 | 11,930 | D | 4,012 | 
| TYLER BRIAN S. | Director, Chief Executive Officer | 2025-08-15 | 11,930 | D | 15,942 | 
| Rutledge Napoleon B JR | SVP, Controller & CAO | 2025-08-08 | 329 | D | 657 | 
| Wilson-Thompson Kathleen | Director | 2025-07-30 | 301 | A | 301 | 
| Lerman Bradley E | Director | 2025-07-30 | 301 | A | 301 | 
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount | 
|---|---|---|---|---|---|---|
| Sheldon Whitehouse | Senator | 2017-10-12 | Sale (Full) | 2017-09-20 | Joint | $15,001 - $50,000 | 
| Sheldon Whitehouse | Senator | 2017-03-15 | Purchase | 2017-02-23 | Joint | $1,001 - $15,000 | 
| Sheldon Whitehouse | Senator | 2016-12-12 | Purchase | 2016-11-15 | Joint | $1,001 - $15,000 | 
| Sheldon Whitehouse | Senator | 2016-11-07 | Purchase | 2016-10-26 | Joint | $1,001 - $15,000 | 
| Sheldon Whitehouse | Senator | 2016-10-07 | Purchase | 2016-09-28 | Joint | $1,001 - $15,000 | 
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount | 
|---|---|---|---|---|---|---|
| Valerie Hoyle | 2025-10-10 | OR04 | Purchase | 2025-09-10 | Spouse | $1,001 - $15,000 | 
| Valerie Hoyle | 2025-10-10 | OR04 | Sale | 2025-09-23 | Spouse | $1,001 - $15,000 | 
| Gilbert Cisneros | 2025-09-12 | CA31 | Sale | 2025-08-05 | — | $1,001 - $15,000 | 
| Jonathan Jackson | 2025-08-25 | IL01 | Purchase | 2025-04-23 | Spouse | $1,001 - $15,000 | 
| Jonathan Jackson | 2025-08-25 | IL01 | Purchase | 2025-03-24 | Spouse | $1,001 - $15,000 | 
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security | 
|---|---|---|---|---|
| Rossmore Private Capital | 2025-09-30 | 6,336,373 | 8,202 | 772.54 | 
| Envestnet Portfolio Solutions, Inc. | 2025-09-30 | 6,323,954 | 8,186 | 772.5329 | 
| LOCKHEED MARTIN INVESTMENT MANAGEMENT CO | 2025-09-30 | 8,111,670 | 10,500 | 772.54 | 
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 2025-09-30 | 619,000 | 801 | 772.784 | 
| Gibbs Wealth Management | 2025-09-30 | 271,934 | 352 | 772.5398 | 
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets | 
|---|---|---|---|---|---|---|
| Meeder Funds | 2025-09-30 | Adviser Class | SRUAX | 13 | 10,043.02 | 0.0041 | 
| Meeder Funds | 2025-09-30 | Institutional Class | SRUIX | 13 | 10,043.02 | 0.0041 | 
| Meeder Funds | 2025-09-30 | Retail Class | FLSPX | 13 | 10,043.02 | 0.0041 | 
| AB PORTFOLIOS | 2025-08-31 | Advisor Class | ABWYX | 1,340 | 920,097.6 | 0.2168 | 
| AB PORTFOLIOS | 2025-08-31 | Class C | ABWCX | 1,340 | 920,097.6 | 0.2168 |